Xinming Li

Xinming Li

Auto-generated profile, based on publicly available information

Xinming Li

State Key Laboratory of Bioreactor Engineering Shanghai Key Laboratory of New Drug Design School of Pharmacy East China University of Science and Technology Shanghai 200237 China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YGYing Gao
Ying Gao
YHYulu Hu
Yulu Hu
QLQimeng Liu
Qimeng Liu
XLXiaokang Li
Xiaokang Li
XLXinming Li
Xinming Li
YGYuan Guo
Yuan Guo

26 September 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
YSYihe Song
Yihe Song
XLXinming Li
Xinming Li
DSDonglei Shi
Donglei Shi
TSTianyue Sun
Tianyue Sun
WLWenwen Liu
Wenwen Liu
JLJian Li
Jian Li
Selective elimination of senescent cells (senolysis) has become a promising therapeutic strategy for the management of chronic renal failure (CRF), but the senolytic molecular pathways towards CRF therapy are limited. Here, we present for the first time a senescence-associated β-galactosidase (SA-β-gal) activatable theragnostic prodrug strategy to pertinently and effectively treat CRF in mice with the aid of fluorescence-guided senolysis. The signs of premature senescence, including the overexpression of β-gal, have been found in kidneys of mice with CRF, making this enzyme particularly suitable as a trigger of prodrugs for CRF therapy. With this unique design, our pioneering prodrug TSPD achieved the activation of a fluorophore for tracking and the specific release of the parent drug, gemcitabine, in β-gal-enriched cells after activation with SA-β-gal. In mice with CRF, abdominal administration of TSPD was effective for improvement of the kidney functions, supporting the feasibility of the SA-β-gal-dependent senolysis therapy towards CRF.

17 September 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
JTJingye Tian
Jingye Tian
DSDonglei Shi
Donglei Shi
YZYanhui Zhang
Yanhui Zhang
XLXiaokang Li
Xiaokang Li
XLXinming Li
Xinming Li
YGYuan Guo
Yuan Guo
Diagnosing aging for preventative intervention generally relies on the tracking of aging biomarkers in the resting state. However, the static marker levels are insufficient to fully evaluate aging, particularly given that the stress response capacity (SRC) decay is currently viewed as a critical feature of aging. Therefore, we have developed a dual-channel fluorescent probe ROKS capable of the logic-based visualization of thiophenol (stressor) and HOCl (thiophenol-activated stress response product) in vivo, which provides a new strategy from the time dimension to precisely assess the SRC of individuals under stress using the dual-channel fluorescence ratio. Using ROKS we observed that the SRC of live cells decayed with senescence, and that a higher SRC was found for young vs. aged Caenorhabditis elegans. As such, our study offers a promising strategy for the fluorescence-guided diagnosis of aging and paves the way for accurate evaluation of the efficacy of anti-aging drugs.

24 February 2021 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
YGYing Gao
Ying Gao
YHYulu Hu
Yulu Hu
QLQimeng Liu
Qimeng Liu
XLXiaokang Li
Xiaokang Li
XLXinming Li
Xinming Li
YGYuan Guo
Yuan Guo